ICON EBITDA 2010-2025 | ICLR

ICON annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • ICON EBITDA for the quarter ending March 31, 2025 was $0.316B, a 27.41% decline year-over-year.
  • ICON EBITDA for the twelve months ending March 31, 2025 was $1.467B, a 9.15% decline year-over-year.
  • ICON 2024 annual EBITDA was $1.586B, a 2.87% increase from 2023.
  • ICON 2023 annual EBITDA was $1.542B, a 13% increase from 2022.
  • ICON 2022 annual EBITDA was $1.365B, a 96.79% increase from 2021.
ICON Annual EBITDA
(Millions of US $)
2024 $1,586
2023 $1,542
2022 $1,365
2021 $694
2020 $458
2019 $525
2018 $439
2017 $400
2016 $371
2015 $339
2014 $255
2013 $167
2012 $111
2011 $78
2010 $126
2009 $149
ICON Quarterly EBITDA
(Millions of US $)
2025-03-31 $316
2024-12-31 $381
2024-09-30 $391
2024-06-30 $379
2024-03-31 $435
2023-12-31 $406
2023-09-30 $419
2023-06-30 $355
2023-03-31 $362
2022-12-31 $346
2022-09-30 $386
2022-06-30 $322
2022-03-31 $312
2021-12-31 $284
2021-09-30 $146
2021-06-30 $128
2021-03-31 $136
2020-12-31 $137
2020-09-30 $111
2020-06-30 $87
2020-03-31 $123
2019-12-31 $139
2019-09-30 $133
2019-06-30 $129
2019-03-31 $125
2018-12-31 $117
2018-09-30 $115
2018-06-30 $99
2018-03-31 $109
2017-12-31 $106
2017-09-30 $101
2017-06-30 $92
2017-03-31 $100
2016-12-31 $100
2016-09-30 $92
2016-06-30 $88
2016-03-31 $91
2015-12-31 $91
2015-09-30 $86
2015-06-30 $82
2015-03-31 $81
2014-12-31 $66
2014-09-30 $73
2014-06-30 $61
2014-03-31 $54
2013-12-31 $41
2013-09-30 $45
2013-06-30 $42
2013-03-31 $141
2012-12-31 $29
2012-09-30 $31
2012-06-30 $28
2012-03-31 $113
2011-12-31 $17
2011-09-30 $11
2011-06-30 $25
2011-03-31 $101
2010-12-31 $121
2010-09-30 $26
2010-06-30 $34
2010-03-31 $36
2009-12-31 $39
2009-09-30 $39
2009-06-30 $37
2009-03-31 $34
Sector Industry Market Cap Revenue
Medical Medical Services $10.566B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.269B 25.37
Elevance Health (ELV) United States $85.392B 11.02
CVS Health (CVS) United States $79.000B 9.82
Cencora (COR) United States $56.052B 19.50
DiDi Global (DIDIY) China $22.921B 34.79
Natera (NTRA) United States $22.013B 0.00
BioMerieux (BMXMF) France $15.348B 0.00
Solventum (SOLV) United States $12.566B 13.30
EUROFINS SCIENT (ERFSF) Luxembourg $12.094B 0.00
CochLear (CHEOY) Australia $11.426B 0.00
Revvity (RVTY) United States $10.766B 18.53
Viatris (VTRS) United States $10.082B 3.46
Doximity (DOCS) United States $9.641B 44.90
Avantor (AVTR) United States $8.879B 12.90
HealthEquity (HQY) United States $8.778B 43.18
Medpace Holdings (MEDP) United States $8.445B 22.43
Sonic Healthcare (SKHHY) Australia $8.256B 0.00
Charles River Laboratories (CRL) United States $6.692B 13.11
Amplifon S.p.A (AMFPF) Italy $4.966B 27.18
Bausch + Lomb (BLCO) Canada $4.050B 23.88
BrightSpring Health Services (BTSG) United States $4.042B 37.42
Sotera Health (SHC) United States $3.463B 19.68
Alignment Healthcare (ALHC) United States $2.978B 0.00
Surgery Partners (SGRY) United States $2.933B 38.14
Concentras Parent (CON) United States $2.751B 15.90
Organon (OGN) United States $2.379B 2.53
Ardent Health Partners (ARDT) United States $2.120B 9.04
GeneDx Holdings (WGS) United States $1.998B 76.94
Premier (PINC) United States $1.885B 14.31
Progyny (PGNY) United States $1.822B 40.09
PACS (PACS) United States $1.494B 0.00
GoodRx Holdings (GDRX) United States $1.354B 27.07
Teladoc Health (TDOC) United States $1.223B 0.00
Pediatrix Medical (MD) United States $1.179B 8.97
Establishment Labs Holdings (ESTA) $1.038B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
CareDx (CDNA) United States $0.978B 15.27
Agilon Health (AGL) United States $0.973B 0.00
Nutex Health (NUTX) United States $0.921B 13.92
AMN Healthcare Services Inc (AMN) United States $0.810B 7.58
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.617B 4.15
InnovAge Holding (INNV) United States $0.547B 0.00
Enhabit (EHAB) United States $0.525B 43.17
LifeMD (LFMD) United States $0.521B 0.00
Auna S.A (AUNA) Luxembourg $0.479B 10.78
SBC Medicals (SBC) United States $0.466B 0.00
Sonida Senior Living (SNDA) United States $0.465B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.395B 0.00
Oncology Institute (TOI) United States $0.278B 0.00
Performant Healthcare (PHLT) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.208B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.146B 0.00
DocGo (DCGO) United States $0.139B 22.67
OncoCyte (OCX) United States $0.095B 0.00
So-Young (SY) China $0.090B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
Sera Prognostics (SERA) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.050B 0.00
Pheton Holdings (PTHL) China $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Basel Medical Group (BMGL) Singapore $0.019B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00